For decades, nutritionists offered simple dietary advice: eat less fat to lower cancer risk. A new study from Yale School of Medicine demolishes that straightforward approach, revealing that not all fats are created equal when it comes to pancreatic cancer.
Researchers discovered that oleic acid, the primary fatty acid in olive oil, actually accelerates tumor growth in pancreatic cancer, while fish oil-derived omega-3 fats slow the disease by roughly 50 percent. The findings, published in Cancer Discovery, suggest that the type of fat consumed matters far more than the total amount.
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers known. Only about 13 percent of patients survive five years after diagnosis. More than 65,000 Americans are expected to receive a PDAC diagnosis this year, with over 50,000 deaths projected. Effective treatment options remain limited, especially for advanced disease.
Christian Felipe Ruiz, lead researcher on the study, emphasized the paradigm shift: "It's really the type of fat that you're consuming, not just total fat content. Depending on the type of fat that you consume, it can go completely different ways."
The oleic acid finding surprised the team. The monounsaturated fat has a reputation as heart-healthy and has been promoted for cardiovascular benefits. Yet in mice carrying a genetic mutation that produces disease resembling human PDAC, oleic acid-rich diets produced tumors faster than control diets.
To isolate the effects of specific fats, researchers created 12 different high-fat diets containing identical calorie counts. The only variable was the fat source. Previous studies had relied on crude methods, often feeding mice lard at 60 percent of total calories, which bears little resemblance to actual human eating patterns and obscures which fatty acids drive cancer risk.
Polyunsaturated fatty acids (PUFAs), particularly omega-3s from fish oil, produced the opposite effect. Mice fed diets enriched with fish oil showed a 50 percent reduction in disease burden compared to those on standard fat diets.
The mechanism involves ferroptosis, a form of programmed cell death triggered by lipid oxidation. When fats become incorporated into cell membranes, their chemical structure determines vulnerability to oxidative damage. PUFAs oxidize easily, making cancer cells susceptible to ferroptosis and death. Monounsaturated fats resist oxidation, shielding cancer cells from this fatal process.
"Monounsaturated fats really protect the cancer cells from lipid oxidation," Ruiz explained. "Because oxidation is reduced, they're less likely to undergo ferroptosis."
The researchers documented a direct dose-response relationship. Increasing the ratio of monounsaturated to polyunsaturated fats worsened disease burden. Decreasing that ratio reduced it.
Interestingly, sex influenced how oleic acid affected cancer growth. Male mice fed oleic acid developed tumors more rapidly, while female mice showed no such acceleration. PUFAs protected both sexes equally, pointing to sex-specific metabolic pathways in cancer development that warrant deeper investigation.
The research has not yet been tested in humans, but the implications may be especially relevant for those at elevated risk: people with chronic pancreatitis, obesity, late-onset diabetes, or a family history of pancreatic cancer.
Ruiz noted the practical gap in current medical guidance: "One of the most common questions clinicians get is 'What can I change in my diet to prevent cancer?' Right now, we don't have clear answers, but this study begins to shed light on how we might address that question."
The team plans next to investigate whether dietary fat composition changes could improve survival for patients already diagnosed with pancreatic cancer. They also want to explore whether blood levels of monounsaturated versus polyunsaturated fats might serve as an early warning marker for pancreatic cancer risk.
Author Jessica Williams: "This research finally cracks the door on a question patients desperately want answered, but it also complicates the olive oil marketing narrative in ways the industry won't love."
Comments